When compared to glioblastoma, thyroid carcinoma, renal cell carcinoma and hepatocellular carcinoma that all express PSMA in the tumour’s neovasculature and not intracellular, ligand uptake in salivary gland tumours is moderate to weak. This evidence concerns the gene FOLH1 and neoplasm.